Literature DB >> 618383

Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.

N A Awan, R R Miller, D T Mason.   

Abstract

We compared cardiocirculatory actions of nitroprusside (NP) to prazosin (PZ) in eleven chronic coronary patients with refractory congestive heart failure. Each drug equally lowered systemic arterial pressures mildly while heart rate was unaltered. NP decline (P less than .001) in left ventricular filling pressure (28 to 17 mm Hg) and rise (P less than .005) in cardiac index (2.20 to 2.96 L/min/m2) were similar to PZ (30 to 17) and (2.08 to 3.00). PZ and NP equally enhanced cardiac efficiency of stroke work and myocardial oxygen consumption index. Total systemic vascular resistance declined (P less than .001) the same with NP and PZ. Forearm vascular resistance (FVR) and venous tone (FVT) diminished equally with NP and PZ. Similar FVR/FVT percent changes of 0.88 and 0.64 with NP and PZ indicated relatively balanced systemic arteriovenous relaxation. Sinze PZ effects persisted six hours with symptomatic improvement, oral PZ is the best vasodilator for long-term use, extending in-hospital NP-like actions to ambulatory heart failure therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 618383     DOI: 10.1161/01.cir.57.1.152

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Use of M-mode echocardiography in clinical pharmacology.

Authors:  D G Gibson
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

Review 2.  Selection of vasodilator drugs for patients with severe chronic heart failure: an approach based on a new classification.

Authors:  M Packer
Journal:  Drugs       Date:  1982-07       Impact factor: 9.546

3.  Prazosin for refractory cardiac failure in children.

Authors:  H Netz; K J Hagel; G Röhner; H W Rautenburg
Journal:  Pediatr Cardiol       Date:  1984       Impact factor: 1.655

Review 4.  The treatment of heart failure. A methodological review of the literature.

Authors:  G H Guyatt
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

5.  Central venous pressure and pulmonary capillary wedge pressure: fresh clinical perspectives from a new model of discordant and concordant heart failure.

Authors:  Tony S Ma; Biykem Bozkurt; David Paniagua; Biswajit Kar; Kumudha Ramasubbu; Carl F Rothe
Journal:  Tex Heart Inst J       Date:  2011

6.  Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation.

Authors:  B E Hockings; G D Cope; G M Clarke; R R Taylor
Journal:  Br Heart J       Date:  1980-05

7.  Serial measurements of left ventricular dimensions by echocardiography. Assessment of week-to-week, inter- and intraobserver variability in normal subjects and patients with valvular heart disease.

Authors:  G O Ladipo; F G Dunn; T H Pringle; B Bastian; T D Lawrie
Journal:  Br Heart J       Date:  1980-09

8.  Haemodynamic effects of a new vasodilator drug, felodipine, in healthy subjects.

Authors:  G Johnsson; G Murray; A Tweddel; I Hutton
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 9.  Innovative drug treatments for viral and autoimmune myocarditis.

Authors:  S Anandasabapathy; W H Frishman
Journal:  J Clin Pharmacol       Date:  1998-04       Impact factor: 3.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.